No increased risk of childhood cancer near UK nuclear sites, study finds

Published Date: 17 Jul 2025

Children living near nuclear power stations in the U.K. are not at increased risk of childhood cancers, according to a new analysis.

Read Full News

Latest News

FDA approves Blenrep for relapsed or refractory multiple myeloma

The U.S. Food and Drug Administration approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma.

Molecular profiling of renal medullary carcinoma identifies TROP2 as a promising therapeutic target

Researchers at The University of Texas MD Anderson Cancer Center, in collaboration with BostonGene, conducted the largest and most comprehensive molecular analysis of renal medullary carcinoma (RMC), a rare and aggressive ...

Radiation therapy for patients with breast cancer

Radiation therapy is a common component of breast cancer treatment for patients. The high-powered beams of intense energy kill cancer cells and reduce the risk of the cancer recurring.

Discovery of breast cancer treatment resistance mechanism could lead to new hope for some

Mayo Clinic researchers have discovered a key reason why certain breast cancers might not respond to an important new class of therapeutics called antibody drug conjugates (ADCs). These treatments pair an antibody that targets ...

AI tool identifies women at high risk of interval breast cancer

In a study of more than 100,000 screening mammograms, researchers demonstrated the potential of an AI tool to help identify women at higher risk of developing interval breast cancer, which is breast cancer that is diagnosed ...

Study finds higher breast cancer rates in areas with more air pollution

Women living in parts of the United States with lower air quality, especially neighborhoods with heavy emissions from motor vehicles, are more likely to develop breast cancer, according to a multiyear analysis involving more ...

Todays Updates

Adenotonsillectomy improves sleep architecture, respiratory outcomes in pediatric obstructive sleep apnea

For pediatric obstructive sleep apnea (OSA), adenotonsillectomy (T&A) significantly improves sleep architecture and respiratory outcomes, according to a study published online Oct. 24 in Laryngoscope.

'Molecular glues' and 'bumpers' offer new hope for precision medicines

New research led by the University of Minnesota Medical School demonstrates that molecules acting as "molecular bumpers" and "molecular glues" can rewire G protein-coupled receptor (GPCR) signaling, turning the cell's busiest ...

Running 'super shoes' may make you faster—but at what cost?

Once seen only on the feet of elite runners at the Olympics and other premier running events, the so-called "super shoe" has moved from racing podiums to pavements.

Scientists find the genetic clues that let humans walk on two legs

Two small changes in human DNA may have played a big role in helping our ancestors walk upright, researchers say.

Dietary fiber, prunes and senna offer relief for constipation discomfort

Big-gun pain relievers can come with unwelcome side effects. At the top of the list for many of these products are constipation and the distress of slowed bowels.

Study finds surprising link between gut and brain rhythms

The human body is packed with natural rhythms, from your sleep-wake cycle to the steady pulsing of blood through the brain to heart rate and pulse.

Migraines and headaches are a global burden that needs greater recognition, international study finds

Modern lifestyles including stress, sedentary activity, caffeine, alcohol and poor-quality sleep remain widespread triggers for migraines and headaches, which affect more than a third of the world's population, according ...

Todays Updates

Adenotonsillectomy improves sleep architecture, respiratory outcomes in pediatric obstructive sleep apnea

For pediatric obstructive sleep apnea (OSA), adenotonsillectomy (T&A) significantly improves sleep architecture and respiratory outcomes, according to a study published online Oct. 24 in Laryngoscope.

'Molecular glues' and 'bumpers' offer new hope for precision medicines

New research led by the University of Minnesota Medical School demonstrates that molecules acting as "molecular bumpers" and "molecular glues" can rewire G protein-coupled receptor (GPCR) signaling, turning the cell's busiest ...

Running 'super shoes' may make you faster—but at what cost?

Once seen only on the feet of elite runners at the Olympics and other premier running events, the so-called "super shoe" has moved from racing podiums to pavements.

Scientists find the genetic clues that let humans walk on two legs

Two small changes in human DNA may have played a big role in helping our ancestors walk upright, researchers say.

Dietary fiber, prunes and senna offer relief for constipation discomfort

Big-gun pain relievers can come with unwelcome side effects. At the top of the list for many of these products are constipation and the distress of slowed bowels.

Study finds surprising link between gut and brain rhythms

The human body is packed with natural rhythms, from your sleep-wake cycle to the steady pulsing of blood through the brain to heart rate and pulse.

Migraines and headaches are a global burden that needs greater recognition, international study finds

Modern lifestyles including stress, sedentary activity, caffeine, alcohol and poor-quality sleep remain widespread triggers for migraines and headaches, which affect more than a third of the world's population, according ...

Latest News

The U.S. Food and Drug Administration approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma.

Researchers at The University of Texas MD Anderson Cancer Center, in collaboration with BostonGene, conducted the largest and most comprehensive molecular analysis of renal medullary carcinoma (RMC), a rare and aggressive ...

Radiation therapy is a common component of breast cancer treatment for patients. The high-powered beams of intense energy kill cancer cells and reduce the risk of the cancer recurring.

Mayo Clinic researchers have discovered a key reason why certain breast cancers might not respond to an important new class of therapeutics called antibody drug conjugates (ADCs). These treatments pair an antibody that targets ...

In a study of more than 100,000 screening mammograms, researchers demonstrated the potential of an AI tool to help identify women at higher risk of developing interval breast cancer, which is breast cancer that is diagnosed ...

Women living in parts of the United States with lower air quality, especially neighborhoods with heavy emissions from motor vehicles, are more likely to develop breast cancer, according to a multiyear analysis involving more ...

News All Time

Smart exercise planning could boost recovery for people with cancer

The periodization of exercise training could give people undergoing cancer treatment and those in recovery a tailored pathway to support strength and resilience during the challenging journey of cancer care and rehabilitation.

AI model combines clinical and magnetic resonance data to improve prediction of breast cancer recurrence

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the main causes of cancer-related mortality. Precisely predicting whether ...

Obesity-related cancer rising among both younger and older adults worldwide, study finds

A surveillance study compared international cancer incidence trends of 13 cancer types in younger and older adults.

Survivors of high-risk neuroblastoma face substantial late effects of modern therapies

Within the last two decades, multiple stem cell transplants and immunotherapy have been added to intensive chemotherapy as the standard of care for high-risk neuroblastoma, drastically improving survival of this childhood ...

mRNA-based COVID vaccines generate improved responses to immunotherapy

Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice as likely to be alive three years after beginning treatment, according to a new study led by researchers ...

Research finds COVID-19 mRNA vaccine sparks immune response to fight cancer

Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine, researchers have found.

Oral drug combination extends progression-free survival in advanced ER-positive breast cancer

Patients with estrogen-receptor-positive HER-2-negative advanced breast cancer showed significantly improved progression-free survival when treated with an oral combination regimen that includes giredestrant, a novel, next-generation ...

Should the UK introduce targeted prostate cancer screening? The case for and against

Former UK prime minister Rishi Sunak has called for a targeted prostate cancer screening program for men most at high risk of the disease, reviving a national debate on how to save more lives and tackle health inequalities ...

Chemotherapy combination boosts overall survival in patients with EGFR-mutant non-small cell lung cancer

In recent research, treatment with osimertinib plus a platinum–pemetrexed chemotherapy combination resulted in statistically significant and clinically meaningful improvement in overall survival in patients with newly diagnosed ...

Leukemia cells evade treatment by reshaping their mitochondria, researchers discover

Researchers from Rutgers Health and other institutions have discovered why a powerful leukemia drug eventually fails in most patients—and found a potential way to overcome that resistance.

Dense breasts: What it means and what women can do about screening

About half of women over 40 have dense breasts. The denser the breast tissue, the more difficult it is to spot cancer on a standard mammogram. Having dense breast tissue can make it harder to detect cancer and sometimes leads ...

High-speed whole-body SPECT tracks tumor evolution to optimize prostate cancer treatment

A new fast and convenient approach to scintigraphy-based monitoring allows physicians to efficiently and reliably assess prostate cancer progression or regression during treatment. With this strong prognostic information, ...

After cancer: Study explores caring-healing modalities for survivors

As cancer survivorship rises, many people living with or beyond cancer face lasting physical and emotional challenges—particularly anxiety and depression, which affect about 30% of this population. Emotional distress is ...

Tumor infiltration of major blood vessels, not metastasis, may be primary cause of cancer death

The ultimate cause of death from cancer may not be metastatic disease, as researchers have long surmised, but an infiltration of tumors into major blood vessels that cause blood clots and multiorgan failure, a one-of-a-kind ...

Study identifies new approach to protect the brain during radiation therapy

While tremendous relief comes from successfully battling cancer, survivors can also experience cognitive impairments caused by the disease and its treatment. Up to 70% of survivors experience trouble with memory and concentration, ...

Breast awareness: What to look for in your self-exam

October is Breast Cancer Awareness Month, and cancer awareness starts with general breast awareness. Dr. Julie Nangia, medical director of breast oncology at the Dan L Duncan Comprehensive Cancer Center, recommends monthly ...

Recommended News For You

Radioligand Shows Promise in Metastatic Hormone-Sensitive Prostate Cancer

AI Model as Effective as Radiologists in Detecting Prostate Cancer on MRI

Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies

Virtual Reality Travel Reduces Cancer Pain.

Researchers find distinct cell receptors with the potential for new treatments.

Upfront TKI for Bone-Predominant RCC Tops Single-Agent Immunotherapy

Researchers identify potential new therapeutic targets for treating T-cell lymphoma and natural killer cell tumors.

Recommended Articles For You

Unleashing Precision Medicine: CRISPR-Cas9 Gene Editing in Hematopoietic Stem Cells 

Understanding Dasatinib: A Promising Drug for Cancer Treatment  

Targeting the Tumor Microenvironment: Next-Generation Strategies for Immuno-Oncology Success 

The Pivotal Role of Telomerase in Breast Cancer Therapy Resistance and Treatment Strategies 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The White House has postponed its plan to outlaw menthol cigarettes indefinitely.

2.

Joe Biden has prostate cancer with bone spread. An oncologist explains what you need to know

3.

Researchers can now forecast how prostate cancer bone metastases will react to radium-223 treatment.

4.

Discovery reveals protein involved in Parkinson's disease also drives skin cancer

5.

Parkinson patient's gait is restored by a spinal cord stimulator.

1.

ctDNA in Aggressive B-Cell Lymphoma: Redefining MRD and Prognostic Monitoring

2.

Uncovering Breast Cancer: The Power of Early Stage Ultrasound

3.

Subarachnoid Hemorrhage: Emerging Insights into Pathophysiology and Future Management

4.

The Dark Side of Melanoma: Uncovering the Risk Factors and Prevention Strategies

5.

Neuroendocrine Tumors: Mechanisms of Mortality, Associated Conditions

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part XII

2.

Updates on Standard V/S High Risk Myeloma Treatment- The Next Part

3.

Updates on the First Line Management of ALK+ NSCLC

4.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective

5.

A New Era in Managing Cancer-Associated Thrombosis

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot